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AIM To describe behavioural and psychiatric outcomes of children within 10 years of
convulsive status epilepticus (CSE).
METHOD Children originally identified by the population-based North London Convulsive
Status Epilepticus in Childhood Surveillance Study were followed-up between July 2009 and
February 2013. They were grouped into epilepsy- and non-epilepsy-related CSE, and
compared with population norms and healthy controls using the Strengths and Difficulties
Questionnaire; the Autism Spectrum Screening Questionnaire; and the Swanson, Nolan, and
Pelham questionnaire. Children who scored above recommended clinical cut-offs on any
scale were invited for a neuropsychiatric assessment. Regression models were fitted to
identify clinically relevant covariates associated with behavioural outcomes.
RESULTS At a mean follow-up of 8.1 years post-CSE, 28% of enrolled children were found to
have a psychiatric disorder. Children with epilepsy-related CSE scored higher than norms on
all scales and children with non-epilepsy-related CSE scored higher than norms on the
Strengths and Difficulties Questionnaire and the Autism Spectrum Screening Questionnaire.
Presence of seizures at baseline and recurrence of CSE was associated with worse outcomes
in the group with epilepsy. Intellectual abilities were associated with behavioural outcomes in
all participants.
INTERPRETATION A large proportion of children manifest behavioural issues 8 years after
CSE. The present data highlight the need for behavioural screening in children with
neurodevelopmental impairments post-CSE.
Convulsive status epilepticus (CSE), the most common
medical emergency in childhood,1 is associated with an
increased risk of long-term mortality,2 structural abnormal-
ities in white matter and the hippocampal region,3,4 neu-
rocognitive and memory impairments,5,6 and an overall
worse quality of life.7 Aetiology is the major determinant
of outcome.8 However, even children with no apparent
pre-existing neurological problems at CSE show evidence
of short-term structural and functional consequences after
CSE.9–12
Most data on long-term outcomes of childhood CSE are
collected from retrospective hospital-based studies involv-
ing adults and children.13,14 To our knowledge, there has
only been one population-based paediatric study investigat-
ing long-term outcomes of childhood CSE, which focused
only on neurological and intellectual outcomes.15 Our pre-
sent study was specifically designed to determine
behavioural outcomes of childhood CSE utilizing in-depth
standardized assessments and a clinical neuropsychiatric
assessment. The inception cohort was from the first popu-
lation-based study focused on the epidemiology of child-
hood CSE, the North London Convulsive Status
Epilepticus in Childhood Surveillance Study.16 Here we
report our findings on the behavioural and psychiatric out-
comes in this unique cohort within 10 years of the initial
CSE episode.
METHOD
Participants and procedures
In this prospective cohort study, we aimed to recruit all
surviving children after CSE originally identified during
the North London Convulsive Status Epilepticus in Child-
hood Surveillance Study (detailed recruitment methods
described elsewhere).2,16 For each participant,
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demographic, medical, developmental data, neuropsychi-
atric diagnosis, and clinical details about their episode of
CSE were obtained from the original North London Con-
vulsive Status Epilepticus in Childhood Surveillance Study
database and their hospital medical records. Subsequently,
all participants and their parents were interviewed by one
of the authors (SP) using a structured proforma to obtain
information on the presence of seizures/epilepsy post-CSE,
CSE recurrence, behavioural problems, psychiatric diagno-
sis, schooling, and any drug treatment or interventions.
Recent studies point to high rates of psychiatric comor-
bidity in active epilepsy.17–19 We wanted to study the out-
comes of children with CSE without the added burden of
ongoing epileptic seizures and/or antiepileptic medication
separately. Therefore, children were classified as (1) chil-
dren who have received an epilepsy diagnosis at any time
point pre- or post-CSE (epilepsy-related CSE) and (2)
children who have never been diagnosed with epilepsy
(non-epilepsy-related CSE).
For the recruitment of healthy controls, we sent emails
to employees of Great Ormond Street Hospital and Young
Epilepsy, a national epilepsy charity. Parents volunteered
participation of their children. Five healthy patient siblings
were also recruited. Exclusion criteria for healthy control
participation were a diagnosis of epilepsy and/or the pres-
ence of neurodevelopmental delay, as reported by their
parents. Indices of multiple deprivation were calculated for
all participants (http://www.ons.gov.uk) and used as proxy
measure for their socio-economic status.
Study participants were sent questionnaires to be com-
pleted by their self-nominated primary carer and invited
for magnetic resonance imaging (MRI) and in-person neu-
ropsychological assessments at University College London
Great Ormond Street Institute of Child Health/Great
Ormond Street Hospital, London. Conventional MRI
sequences were acquired on an Avanto 1.5 Tesla scanner
(Siemens, Erlangen, Germany). Images were reviewed by
two experienced paediatric neuroradiologists who agreed
by consensus whether scans were (1) normal, (2) abnormal
but of uncertain clinical significance, or (3) abnormal but
clinically significant. The Wechsler Abbreviated Scale of
Intelligence was used to obtain a Full-scale IQ at this
appointment.20
Behavioural questionnaires
We selected three scales for parent completion that have
been validated in large-scale studies and are in widespread
clinical use: (1) the Strengths and Difficulties Question-
naire (SDQ; a 25-item checklist designed to screen for
emotional, peer, conduct, and hyperactivity problems); (2)
the Autism Spectrum Screening Questionnaire (ASSQ; a
27-item checklist designed to screen for features of aut-
ism); and (3) the Swanson, Nolan, and Pelham Question-
naire (SNAP-IV; an 18-item checklist designed to screen
for attention-deficit–hyperactivity disorder [ADHD] traits).
A higher score on these scales indicates the presence of
more behavioural problems. The population mean for the
SDQ (8.4 [SD 5.8]) was derived from the SDQ website
(http://www.sdqinfo.org/). The ASSQ population mean
(3.3 [SD 4.5]) was derived from the ‘Bergen Child
Study’,21 and the SNAP-IV population mean (0.75 [SD
0.75]) was derived from the study of Bussing et al.22 For
scoring purposes we used the online SDQ algorithm that
allowed us to extract an overall behaviour index and
address missing items accordingly (https://sdqscore.org/
Amber). The ASSQ and SNAP-IV were scored manually.
In instances of missing items we substituted those with the
personal mean score, that is, average of remaining items on
the scale. This method has been shown to be appropriate
for dealing with missing data items (<2%).23 Those that
passed an a priori determined clinical cut-off (SDQ: 17;
ASSQ: 17; SNAP-IV: 1.67)24 on at least one behavioural
questionnaire were invited along with their parents to
attend a semi-structured interview and assessment con-
ducted by an experienced child and adolescent psychiatrist
(CG).
Neuropsychiatric assessment
Clinical diagnosis of psychiatric disorders was made by
CG in accordance with the Diagnostic and Statistical Man-
ual of Mental Disorders, 4th Edition criteria.25 All relevant
material used in this semi-structured interview can be
found in Appendix S1 (online supporting information). In
brief, the child and carers were interviewed using a set list
of diagnostic question items and a neurological examina-
tion of the child was carried out in this session to detect
the presence of developmental coordination disorder. At
the beginning of the appointment, CG was blind to clinical
details such as CSE group and results of previous investi-
gations, but was aware that these children had scored
higher than the clinical cut-off on at least one screening
questionnaire.
Statistical analysis
Analyses were conducted with Predictive Analytics Soft-
ware version 21 (IBM Chicago, IL, USA) for Windows. A
p value of 0.050 was used as the cut-off point for statistical
significance. Independent sample t-tests, analysis of vari-
ance, Mann–Whitney U tests, and v2 tests were used for
group comparisons. One-sample t-test was conducted to
compare group means with population-derived means. We
also ran the above analysis separately for patients with pro-
longed febrile seizures (PFS), who are known to be neuro-
logically normal at CSE. A multivariate analysis of variance
was performed to compare performance of the epilepsy
CSE patient groups and controls on the behavioural scales.
Bootstrapping using 1000 samples was applied to all our
What this paper adds
• Eight years post convulsive status epilepticus (CSE), 37% of parents report
behavioural issues.
• Of enrolled children, 28% were found to have a Diagnostic and Statistical
Manual mental disorder.
• Intellectual abilities are strongly associated with behavioural outcomes in
children post-CSE.
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statistical tests as the distribution of some values was found
to deviate from the normal distribution.
To reduce the dimensionality of our data set we ran a
principal component analysis, which included all individual
items on the SDQ (n=25), ASSQ (n=27), and SNAP-IV
(n=18) (total items=70). The principal component analysis
resulted in a first principal component (mean=0, med-
ian=0.19), which accounted for the majority (84%) of vari-
ability in the behavioural outcomes data. For this reason,
this single principal component (hereinafter behavioural
outcomes factor) became the outcome of focus of the anal-
yses. We ran univariable regression analyses separately for
the two patient groups. The following independent covari-
ates were investigated at the time of CSE: (1) age at CSE;
(2) developmental delay reported by parents (yes/no); (3)
prior seizure activity at baseline (yes/no); (4) duration of
CSE (min); (5) whether CSE was continuous (yes/no); (6)
whether CSE was focal (yes/no). We also included two
clinical covariates collected at follow-up: (7) recurrence of
CSE (yes/no); (8) structural abnormalities present on the
MRI as these have been shown to be associated with worse
outcomes in other studies. Covariates associated with
p<0.100 coefficients in the univariable analysis were
entered into a linear regression to determine our final mul-
tivariable regression models for the groups.
Ethics approval
The study was approved by the University College London
Institute of Child Health/Great Ormond Street Hospital
research ethics committee. We obtained written informed
consent from all participants’ parents/guardians, and,
where appropriate, we obtained assent from the partici-
pants.
RESULTS
We had data available on 134 (66%) of 203 survivors from
the inception CSE cohort, a mean of 8.1 years post-CSE
(range 5–10) (see Fig. 1 for recruitment details). There
were no differences between the 134 study participants and
the 69 dropouts on CSE related, clinical, and demographic
characteristics (see Table I).
Thirty-one children (23%; 27 epilepsy CSE, four non-
epilepsy CSE) had a community neuropsychiatric diagnosis
before entering the current study. With the exception of
two children who had pre-existing neuropsychiatric
diagnosis at the time of their CSE, all children with CSE
with neuropsychiatric diagnoses had their diagnosis during
follow-up. Nine were diagnosed as having ADHD and 22
as having autism spectrum disorder.
Questionnaire results compared with population norms
and controls
Of the 134 patients enrolled in our study, 83 provided
completed behaviour questionnaires (see Table SI, online
supporting information). v2 tests revealed that children
who entered the study but did not complete behavioural
questionnaires (n=51) were significantly more likely to be
untestable on neuropsychological assessments owing to
their cognitive impairments (v2 [2]=21.04; p<0.001) than
the 83 who provided questionnaire data. Group compar-
isons between those who provided questionnaires (n=83)
and dropouts (n=69) revealed no significant differences
between the two groups.
Table II contains the means of scores for the SDQ,
ASSQ, and SNAP-IV for all groups. One-sample t-test
revealed that (1) the epilepsy CSE group scored signifi-
cantly higher than normative means on the SDQ
(p=0.001), the ASSQ (p=0.001), and the SNAP-IV
(p=0.021) scales; (2) the non-epilepsy CSE group scored
significantly higher than the normative means on the SDQ
(p=0.018) and the ASSQ (p=0.027) scales; and (3) the con-
trols scored lower than the normative means on the SDQ
(p=0.022) and the SNAP-IV (p=0.001) scales. Additional
t-tests showed that children with PFS scored significantly
higher than normative means on the ASSQ (p=0.026).
On group comparisons, there were no differences in
SES and sex between the two patient groups and controls.
Non-epilepsy children with CSE were younger at testing
(p<0.001) and the epilepsy CSE group had lower Full-scale
IQ (p<0.001) in comparison with the control and the non-
epilepsy CSE groups. A multivariate analysis of variance
with age at test and Full-scale IQ as covariates and SDQ,
ASSQ, and SNAP-IV scores as dependent variables
revealed a significant effect of Full-scale IQ (F [3,74]
=11.05; p<0.001) and a trend for an effect of group (F
[3,75]=2.6; p=0.067) on behavioural scores. Pairwise com-
parisons revealed a trend for a difference between the non-
epilepsy CSE and the control group on the SDQ scale (F
[2,76]=3.07; p=0.063).
Regression analyses
Presence of seizures pre-CSE (F [1,35]=8.23; p=0.008) and
recurrent CSE [F (1,35)=2.21; p=0.075 (trend) were associ-
ated with the behavioural outcomes factor in the epilepsy
CSE group in the univariable analyses (Table SII, online
supporting information). Both (seizures: B=1.08 [p=0.008];
recurrence: B=0.64 [p=0.045]) were retained as significant
covariates in our multivariable model of the behavioural
outcomes factor (R2=0.28; p=0.004). In the non-epilepsy
group, MRI abnormalities, focal CSE, and recurrence
revealed trends for an association with the behavioural out-
comes factor but were no longer significant covariates in
the multivariable model.
Neuropsychiatric assessment
Thirty-one patients (37% of respondents; 19 epilepsy
CSE) were above the clinical cut-off on at least one beha-
vioural scale (Table SIII, online supporting information)
and were invited for an in-person neuropsychiatric assess-
ment (see Fig. 2). Ten of the 29 children with PFS in our
sample were also above at least one clinical cut-off. Nine-
teen children (11 epilepsy CSE) had neuropsychiatric
assessment. One family refused to attend and 11 families
did not show up for their scheduled appointments. Three
Behavioural Outcomes after Childhood CSE Marina M Martinos et al. 411
children out of the non-attendees were already diagnosed
with a psychiatric disorder (two with ADHD and one with
autism spectrum disorder). Mann–Whitney U tests
revealed no significant differences between children who
did and did not attend the clinic appointment with the
exception of the SNAP-IV scale where those who attended
had significantly higher SNAP-IV scores (p=0.02) than
non-attendees.
All except one of the children who attended the clinic
were diagnosed with a neuropsychiatric disorder
(Table SIV, online supporting information). Six of these
received a primary diagnosis of autism, eight received a
primary diagnosis of ADHD, and three received a diagno-
sis of autism plus ADHD. One child was diagnosed as hav-
ing pervasive developmental disorder not otherwise
specified and four children met criteria for developmental
coordination disorder. Six out of the 19 children were
diagnosed with a disorder for the first time.
Of children who had a community diagnosis and a psy-
chiatric assessment, there was concordance in diagnosis in
22. Of the remainder, an autism diagnosis in the commu-
nity was revised to an ADHD diagnosis and an ADHD
diagnosis was revised to an autism diagnosis. ADHD was
codiagnosed in three children with autism, and develop-
mental coordination disorder was codiagnosed in two chil-
dren with autism and two children with ADHD.
In total, 37 of 134 enrolled participants (28%) had a
psychiatric disorder in our cohort, many of whom had
been diagnosed in the community. However, with addi-
tional assessment in this study, 15 of the 37 were either
226 patients identified during NLSTEPSS
23 died
203 potential participants
49
refusals
20 lost
to
follow-
up
134 participants
83 participants
completed
questionnaires
(44 epilepsy CSE,
39 non-epilepsy CSE)  
51 participants did not
complete
questionnaires 
(39 epilepsy CSE,
12 non-epilepsy CSE)
Figure 1: Patient recruitment flow chart. NLSTEPSS, North London Convulsive Status Epilepticus in Childhood Surveillance Study; CSE, convulsive status
epilepticus. Non-participants are indicated lighter shade. [Colour figure can be viewed at wileyonlinelibrary.com].
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newly diagnosed conditions (n=6), had their diagnosis
revised (n=2), or had an additional diagnosis (n=7). Of
these, eight did not have epilepsy, so their behavioural
problems cannot be attributed to ongoing epilepsy and/or
the use of antiepileptic medications during a vulnerable
developmental period.
DISCUSSION
This is the first population-based study focused on long-
term behavioural outcomes after childhood CSE using
carefully designed, standardized questionnaires, as well as
in-depth neuropsychiatric interviews. We found that 37%
of patients, whose parents completed the questionnaires,
revealed behavioural problems as they scored above the
clinical cut-off on at least one behavioural scale. In addi-
tion, 28% of patients had received a community diagnosis
and/or were diagnosed with a DSM-IV psychiatric disorder
in the present study, including six children not previously
identified in the community. The comparison of beha-
vioural scores to sex- and socio-economic status-matched
controls, as well as to population norms, confirmed the
presence of behavioural issues in both the epilepsy and
non-epilepsy CSE groups.
A recent study published on quality of life in epilepsy
found that CSE is independently associated with a worse
quality of life.7 This may be directly related to the higher
rate of behavioural issues that are reported in the present
paper. Behavioural problems were found in 43% of chil-
dren with epilepsy-related CSE, which is similar to the
prevalence of psychiatric disorders in children with epi-
lepsy, regardless of a history of CSE.17–19 However, beha-
vioural problems were still present in a high proportion of
those with non-epilepsy-related CSE (31%), as well as
children who had PFS (35%). Together these results could
suggest that CSE itself, irrespective of aetiology, causes
subsequent behavioural problems or that the effect of CSE
on behaviour is mediated by another mechanism that pre-
disposes the child to having both CSE and behavioural
problems.
The lack of association between CSE seizure characteris-
tics (e.g. duration) and behavioural outcomes in our study
could suggest that it is not CSE per se that has a direct
impact on outcome. However, all the children in the
cohort had seizures lasting at least 30 minutes, so we can-
not exclude the possibility of a lower critical threshold
where seizure duration may affect behavioural outcomes.
In addition, seizures before CSE, as well as CSE recur-
rence, were found to be associated with worse behavioural
outcomes in the epilepsy CSE group. Other studies have
also revealed a relationship between past seizure activity
and worse outcomes,4 and such findings may be related to
the multiple insult hypothesis, whereby CSE plus more sei-
zures equals worse outcomes than CSE alone or seizures
alone.
Our data show that children with behavioural difficulties
may go undetected by medical services, possibly owing to a
phenomenon known as ‘diagnostic overshadowing’
whereby the presence of another condition deprioritizes
the detection of other conditions. Conversely, it is equally
plausible that children that have no ongoing medical issues
do not get seen by medical professionals and their prob-
lems go undetected for years. This seems to be true of the
children with non-epilepsy CSE as only four were diag-
nosed with a psychiatric condition in the community,
whereas 12 scored higher than clinical cut-offs in our
study, and eight of 39 respondents were diagnosed with a
DSM-IV disorder. Full-scale IQ was shown to have a
Table I: Demographic and clinical characteristics of participants with
convulsive status epilepticus (CSE) and participants without (non-CSE)
CSE (n=134) Non-CSE (n=69)
Sex (female/male) 67/67 34/35
Mean (SD) age at CSE (mo) 46 (40.7) 50.3 (47)
Mean (SD) SES 33.2 (15) 35.3 (12.9)
Ethnicity
White 54 20
Black 22 18
Asian 41 21
Mixed 7 4
Other 10 6
Full term (>36wks) 109/132 (83) 54/59 (92)
Seizures before CSE 77 (57.5) 40 (58)
Normal cognitive
development before CSEa
68 (51) 37/63 (59)
Median (IQR) duration
of CSE (min)
70 (45–100) 63 (50–101)
Focal CSE 48 (36) 38 (55)
Continuous CSE 70 (52) 29 (42)
aAs reported by parents at the time of CSE. Data are n (%) unless
otherwise indicated. SES, socio-economic status; IQR, interquartile
range.
Table II: Means for patient and control groups on the Strengths and
Difficulties Questionnaire (SDQ); Autism Spectrum Screening Question-
naire (ASSQ); and Swanson, Nolan, and Pelham (SNAP) Questionnaire
Group
Epilepsy
CSE
Non-
epilepsy
CSE Controls
Population-
derived
norms
Sex
(female/
male)
20/24 19/20 9/7 NA
Age
at test
13y 1moa 10y 3moa 12y 4moa NA
SES (SD) 33.6 (14.4) 31.6 (16.1) 26.9 (16.4) NA
FSIQ (SD) 72.2 (17.6)a 100.9 (16.6)a 108.1 (13.2)a 100 (15)
SDQ (SD) 15.1 (7) 11 (6.7)b 5.3 (4.7)b 8.44 (5.8)
SDQ
(range)
3–29 1–29 0–14 –
ASSQ
(SD)
16.1 (11) 7.8 (8.6) 2.9 (3.8) 3.29 (4.5)
ASSQ
(range)
0–40 0–39 0–15
SNAP-IV 1 (0.7) 0.5 (0.6) 0.3 (0.3) 0.75 (0.75)
SNAP-IV
(range)
0–2.4 0–2.6 0–1.1 –
aStatistically significant difference at the p<0.050 level. bStatistically
significant difference at the p<0.050 level on the multivariate analysis
of variance with Full-scale IQ (FSIQ) and age as covariates. CSE, con-
vulsive status epilepticus; NA, not applicable.
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strong association with long-term behavioural outcomes,
which suggests that it could be useful in the early identifi-
cation of children with behavioural problems post-CSE.
Limitations
A possible limitation of the present study is that only 41%
of the inception cohort returned our questionnaire. How-
ever, the baseline characteristics of children who provided
completed questionnaires and dropouts were well matched.
Non-completion of questionnaires in the enrolled sample
was elected by parents whose children were more likely to
be neurologically compromised at baseline; diagnosed with
epilepsy during follow-up; and unable to complete neu-
ropsychological assessments. While our questionnaires
were selected to pick up a wide gamut of behavioural
issues, many of the composing items are not applicable in
children with severe intellectual disability. The fact that
parents of children with more neurodevelopmental prob-
lems opted out of completing our questionnaires combined
with the finding that intellectual abilities are tightly linked
to mental health suggests that our estimates of behavioural
issues in children after CSE are most likely conservative.
An in-person assessment for each study participant would
have been ideal, although more resource intensive. Like-
wise, standardized neuropsychological testing at CSE base-
line would have been preferable to parental/medical report
of abilities,6 utilized as a proxy of developmental delay in
this study. Such formal measures would have allowed the
recruitment of control groups equated for Full-scale IQ at
baseline and led to the systematic apportioning of CSE
and other contributions to long-term behavioural out-
comes.
In addition, it could be argued that it would have been
more appropriate to classify CSE into PFS and non-PFS,
134 participants
83 questionnaires 51 no questionnaires 
31 scored above
clinical cut-off
52 scored
below
19
attended
our clinic
12 did
not
attend
18
received a
psychiatric
diagnosis
3 had a
psychiatric
diagnosis 
in the
community
5 had a
psychiatric
diagnosis 
in the
community
11 had a
community
diagnosis
37 TOTAL
12 had a 
psychiatric
diagnosis in
the
community
6 received
a first
time
diagnosis
Figure 2: Psychiatric diagnosis flow chart. [Colour figure can be viewed at wileyonlinelibrary.com].
414 Developmental Medicine & Child Neurology 2018, 60: 409–416
but even when children with PFS were looked at in isola-
tion they still showed significant behavioural problems,
which is consistent with the report of developmental prob-
lems in children with PFS at 1-year post-CSE.6,12 Finally,
adding a control group with motor and cognitive impair-
ments unrelated to a diagnosed neurological condition may
have been helpful in teasing apart the contributions to
behavioural outcomes of CSE/epilepsy-related and motor/
cognitive-related factors, but such a group would have
been difficult to obtain.
CONCLUSION
A large proportion of children manifest behavioural and
psychiatric issues 8 years post-CSE. These findings sup-
port the systematic screening of children for behavioural/
psychiatric disorders post-CSE akin to the ones proposed
for new-onset epilepsies.26 Intellectual abilities have been
shown to be strongly correlated with behavioural outcomes
and can therefore be used in guiding the early identifica-
tion of vulnerable cases.
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and non-participants
Table SII: Behavioural outcomes factor univariable regression
results
Table SIII: Number of participants scoring above clinical cut-
offs on Strengths and Difficulties; Autism Spectrum Screening;
and Swanson; Nolan, and Pelham questionnaires
Table IV: Diagnosis for children who attended neuropsychi-
atric interview
REFERENCES
1. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epi-
demiology of status epilepticus. J Clin Neurophysiol 1995;
12: 316–25.
2. Pujar SS, Neville BG, Scott RC, et al. Death within
8 years after childhood convulsive status epilepticus: a
population-based study. Brain 2011; 134: 2819–27.
3. Yoong M, Seunarine K, Martinos M, Chin RF, Clark
CA, Scott RC. Prolonged febrile seizures cause reversi-
ble reductions in white matter integrity. Neuroimage Clin
2013; 3: 515–21.
4. Yoong M, Martinos MM, Chin RF, Clark CA, Scott
RC. Hippocampal volume loss following convulsive sta-
tus epilepticus is not limited to prolonged febrile sei-
zures. Epilepsia 2013; 54: 2108–15.
5. Martinos MM, Yoong M, Patil S, et al. Recognition
memory is impaired in children after prolonged febrile
seizures. Brain 2012; 135: 3153–64.
6. Martinos MM, Yoong M, Patil S, et al. Early develop-
mental outcomes in children following convulsive status
epilepticus: a longitudinal study. Epilepsia 2013; 54:
1012–9.
7. Ferro MA, Chin RF, Camfield CS, et al. Convulsive sta-
tus epilepticus and health-related quality of life in chil-
dren with epilepsy. Neurology 2014; 83: 752–7.
8. Raspall-Chaure M, Chin RF, Neville BG, Bedford H,
Scott RC. The epidemiology of convulsive status epilep-
ticus in children: a critical review. Epilepsia 2007; 48:
1652–63.
9. Lewis DV, Shinnar S, Hesdorffer DC, et al. Hippocam-
pal sclerosis after febrile status epilepticus: the FEB-
STAT study. Ann Neurol 2014; 75: 178–85.
10. Nishiyama M, Nagase H, Tanaka T, et al. Demograph-
ics and outcomes of patients with pediatric febrile con-
vulsive status epilepticus. Pediatr Neurol 2015; 52: 499–
503.
11. Tsai ML, Hung KL, Tsan YY, Tung WT. Long-term
neurocognitive outcome and auditory event-related
potentials after complex febrile seizures in children. Epi-
lepsy Behav 2015; 47: 55–60.
12. Weiss EF, Masur D, Shinnar S, et al. Cognitive func-
tioning one month and one year following febrile status
epilepticus. Epilepsy Behav 2016; 64: 283–8.
13. Maytal J, Shinnar S, Moshe SL, Alvarez LA. Low mor-
bidity and mortality of status epilepticus in children.
Pediatrics 1989; 83: 323–31.
14. DeLorenzo RJ, Hauser WA, Towne AR, et al. A
prospective, population-based epidemiologic study of
status epilepticus in Richmond. Virginia. Neurology 1996;
46: 1029–35.
15. Verity CM, Ross EM, Golding J. Outcome of childhood
status epilepticus and lengthy febrile convulsions: find-
ings of national cohort study. BMJ 1993; 307: 225–8.
16. Chin RF, Neville BG, Peckham C, et al. Incidence,
cause, and short-term outcome of convulsive status
epilepticus in childhood: prospective population-based
study. Lancet 2006; 368: 222–9.
17. Reilly C, Atkinson P, Das KB, et al. Parent- and tea-
cher-reported symptoms of ADHD in school-aged chil-
dren with active epilepsy: a population-based study. J
Atten Disord 2017; 21: 887–97.
18. Reilly C, Atkinson P, Das KB, et al. Features of autism
spectrum disorder (ASD) in childhood epilepsy: a popu-
lation based study. Epilepsy Behav 2015; 42: 86–92.
Behavioural Outcomes after Childhood CSE Marina M Martinos et al. 415
19. Sundelin HE, Larsson H, Lichtenstein P, et al. Autism
and epilepsy: a population-based nationwide cohort
study. Neurology 2016; 87: 192–7.
20. Wechsler D. Wechsler Abbreviated Scale of Intelligence.
New York: The Harcourt Brace, 1999.
21. Posserud MB, Lundervold AJ, Gillberg C. Autistic fea-
tures in a total population of 7-9-year-old children
assessed by the ASSQ (Autism Spectrum Screening
Questionnaire). J Child Psychol Psychiatry 2006; 47: 167–
75.
22. Bussing R, Fernandez M, Harwood M, et al. Parent and
teacher SNAP-IV ratings of attention deficit hyperactiv-
ity disorder symptoms: psychometric properties and nor-
mative ratings from a school district sample. Assessment
2008; 15: 317–28.
23. Peyre H, Leplege A, Coste J. Missing data methods for
dealing with missing items in quality of life question-
naires. A comparison by simulation of personal mean
score, full information maximum likelihood, multiple
imputation, and hot deck techniques applied to the SF-
36 in the French 2003 decennial health survey. Qual Life
Res 2011; 20: 287–300.
24. Swanson JM. Sample SNAP-IV Teacher and Parent
Rating Scale # 6160. Available at: http://www.myadhd.c
om/snap-iv-6160-18sampl.html (accessed 31 October
2017).
25. American Psychiatric Association. Diagnostic and Statis-
tical Manual of Mental Disorders. 4th ed. Washington,
DC: Author, 2000.
26. Eom S, Fisher B, Dezort C, Berg AT. Routine develop-
mental, autism, behavioural, and psychological screening
in epilepsy care settings. Dev Med Child Neurol 2014; 56:
1100–5.
416 Developmental Medicine & Child Neurology 2018, 60: 409–416
